Karin Witzeneder1, Andrea Lindenmair2, Christian Gabriel1, Katharina Höller1, Denise Theiß1, Heinz Redl2, Simone Hennerbichler1. 1. Red Cross Blood Transfusion Service of Upper Austria, Linz, Linz/Vienna, Austria ; Austrian Cluster for Tissue Regeneration, Linz/Vienna, Austria. 2. Austrian Cluster for Tissue Regeneration, Linz/Vienna, Austria ; Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, Linz/Vienna, Austria.
Abstract
OBJECTIVE: The need for an alternative to fetal bovine serum (FBS) is known to scientists and users involved in cell therapy or advanced therapy medicinal products. Human serum (huS) and platelet lysate (hPL) can be used as alternatives resulting in similar or even superior results concerning cell expansion. METHODS: We developed protocols for the production of huS and two types of hPL and tested them in the expansion of human fibroblasts and adipose tissue-derived stem cells (ASC). Quality control included cell counts (platelets, red and white blood cells), sterility testing, pH levels, total protein concentrations and growth factor levels. ASC and fibroblasts were expanded for three passages in media supplemented with FBS, huS or hPL and evaluated microscopically. Proliferation in terms of population doubling times (PDT) was determined. In case of ASC, differentiation was performed as well. RESULTS: All three alternatives demonstrated shorter PDT for fibroblasts and ASC compared to FBS. Furthermore, ASC maintained their differentiation potential. CONCLUSION: We conclude that hPL and huS can be used as alternatives to FBS for the cultivation and expansion of cells intended for human use.
OBJECTIVE: The need for an alternative to fetal bovine serum (FBS) is known to scientists and users involved in cell therapy or advanced therapy medicinal products. Human serum (huS) and platelet lysate (hPL) can be used as alternatives resulting in similar or even superior results concerning cell expansion. METHODS: We developed protocols for the production of huS and two types of hPL and tested them in the expansion of human fibroblasts and adipose tissue-derived stem cells (ASC). Quality control included cell counts (platelets, red and white blood cells), sterility testing, pH levels, total protein concentrations and growth factor levels. ASC and fibroblasts were expanded for three passages in media supplemented with FBS, huS or hPL and evaluated microscopically. Proliferation in terms of population doubling times (PDT) was determined. In case of ASC, differentiation was performed as well. RESULTS: All three alternatives demonstrated shorter PDT for fibroblasts and ASC compared to FBS. Furthermore, ASC maintained their differentiation potential. CONCLUSION: We conclude that hPL and huS can be used as alternatives to FBS for the cultivation and expansion of cells intended for human use.
Entities:
Keywords:
Fetal bovine serum; Human adipose tissue-derived stem cells; Human platelet lysate; Human serum; Regenerative medicine
Authors: Caroline Rauch; Elisabeth Feifel; Eva-Maria Amann; Hans Peter Spötl; Harald Schennach; Walter Pfaller; Gerhard Gstraunthaler Journal: ALTEX Date: 2011 Impact factor: 6.043
Authors: Susanne Wolbank; Guido Stadler; Anja Peterbauer; Astrid Gillich; Michael Karbiener; Berthold Streubel; Matthias Wieser; Hermann Katinger; Martijn van Griensven; Heinz Redl; Christian Gabriel; Johannes Grillari; Regina Grillari-Voglauer Journal: Tissue Eng Part A Date: 2009-07 Impact factor: 3.845
Authors: Jasmin Kemptner; Karin Witzeneder; Simone Hennerbichler; Christian Gabriel Journal: Transfus Med Hemother Date: 2013-11-29 Impact factor: 3.747
Authors: F Hildner; M J Eder; K Hofer; J Aberl; H Redl; M van Griensven; C Gabriel; A Peterbauer-Scherb Journal: J Tissue Eng Regen Med Date: 2013-01-09 Impact factor: 3.963
Authors: Michael Lohmann; Gudrun Walenda; Hatim Hemeda; Sylvia Joussen; Wolf Drescher; Stefan Jockenhoevel; Gabriele Hutschenreuter; Martin Zenke; Wolfgang Wagner Journal: PLoS One Date: 2012-05-25 Impact factor: 3.240
Authors: Alexander Rühle; Ramon Lopez Perez; Bingwen Zou; Anca-Ligia Grosu; Peter E Huber; Nils H Nicolay Journal: Stem Cell Rev Rep Date: 2019-06 Impact factor: 5.739
Authors: Amel Dudakovic; Emily Camilleri; Scott M Riester; Eric A Lewallen; Sergiy Kvasha; Xiaoyue Chen; Darcie J Radel; Jarett M Anderson; Asha A Nair; Jared M Evans; Aaron J Krych; Jay Smith; David R Deyle; Janet L Stein; Gary S Stein; Hee-Jeong Im; Simon M Cool; Jennifer J Westendorf; Sanjeev Kakar; Allan B Dietz; Andre J van Wijnen Journal: J Cell Biochem Date: 2014-10 Impact factor: 4.429
Authors: Jasmin Kemptner; Karin Witzeneder; Simone Hennerbichler; Christian Gabriel Journal: Transfus Med Hemother Date: 2013-11-29 Impact factor: 3.747
Authors: Michael V Fiandalo; John H Wilton; Krystin M Mantione; Carol Wrzosek; Kristopher M Attwood; Yue Wu; James L Mohler Journal: Prostate Date: 2017-12-01 Impact factor: 4.104